
64Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133+ cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite
Keywords: 64Cu-ATSM; DNA repair; Nucleic acid antimetabolite; Hypoxia; Internal radiotherapy; 18FDG; [18F]-fluorodeoxyglucose; 5-FU; 5-fluorouracil; 64Cu-ATSM; 64Cu-diacetyl-bis (N4-methylthiosemicarbazone); 6-TG; 6-thioguanine; ANOVA; analysis of variance; ASB9; a